Related Experiment Video
Updated: Jan 30, 2026
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma
Catherine Lee1,2, Vasilisa A Rudneva3, Serap Erkek4,5,6
1Tumor Initiation and Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA.
Abstract:
Drugs that modify the epigenome are powerful tools for treating cancer, but these drugs often have pleiotropic effects, and identifying patients who will benefit from them remains a major clinical challenge. Here we show that medulloblastomas driven by the transcription factor Gfi1 are exquisitely dependent on the enzyme lysine demethylase 1 (Kdm1a/Lsd1). We demonstrate that Lsd1 physically associates with Gfi1, and that these proteins cooperate to inhibit genes involved in neuronal commitment and differentiation. We also show that Lsd1 is essential for Gfi1-mediated transformation: Gfi1 proteins that cannot recruit Lsd1 are unable to drive tumorigenesis, and genetic ablation of Lsd1 markedly impairs tumor growth in vivo. Finally, pharmacological inhibitors of Lsd1 potently inhibit growth of Gfi1-driven tumors. These studies provide important insight into the mechanisms by which Gfi1 contributes to tumorigenesis, and identify Lsd1 inhibitors as promising therapeutic agents for Gfi1-driven medulloblastoma.
Insights
Transcription factor Gfi1-driven medulloblastomas depend on lysine demethylase 1 (Kdm1a/Lsd1). Lsd1 inhibitors show promise for treating these specific cancers.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Epigenetic drugs offer cancer treatment potential but face challenges due to pleiotropic effects.
- Identifying patient subgroups responsive to epigenetic therapies is crucial for clinical success.
Purpose of the Study:
- To investigate the dependency of Gfi1-driven medulloblastomas on lysine demethylase 1 (Kdm1a/Lsd1).
- To explore the therapeutic potential of targeting Lsd1 in Gfi1-driven medulloblastoma.
Main Methods:
- Assessed the physical association between Gfi1 and Lsd1.
- Evaluated the role of Lsd1 in Gfi1-mediated gene regulation and cellular transformation.
- Investigated the impact of Lsd1 genetic ablation and pharmacological inhibition on tumor growth in vivo.
Main Results:
- Gfi1 and Lsd1 physically associate and cooperate to suppress neuronal differentiation genes.
- Lsd1 is essential for Gfi1-mediated transformation; impaired Lsd1 recruitment prevents tumorigenesis.
- Genetic ablation of Lsd1 significantly hinders Gfi1-driven medulloblastoma growth.
- Pharmacological Lsd1 inhibitors effectively suppress Gfi1-driven tumor progression.
Conclusions:
- Gfi1-driven medulloblastomas exhibit a critical dependence on Lsd1 activity.
- Lsd1 inhibition represents a promising therapeutic strategy for patients with Gfi1-driven medulloblastoma.
Related Concept Videos
01:13Therapeutic Index
01:15Techniques of therapeutic communication I: Active Listening, Sharing Observations, Validation, and Using Touch
Therapeutic communication is not the same as social interaction. Social interaction has no goal or purpose and consists of casual information sharing, whereas therapeutic communication has a plan or purpose for the conversation. Therapeutic...
01:30Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
01:26Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
01:29Microorganisms in Medicine and Therapeutics
01:30Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...